Epigral to host investor plant visit at Dahej facility on October 22
- Epigral Limited scheduled an investor and analyst plant visit for October 22, 2026
- The event will take place at the company's Dahej, Gujarat facility
- Elara Securities (India) Pvt. Ltd. is organizing the visit
- No unpublished price sensitive information will be shared during the tour
*this image is generated using AI for illustrative purposes only.
Epigral Limited will host an investor and analyst plant visit at its Dahej, Gujarat facility on Thursday, October 22, 2026. The event is organized in collaboration with Elara Securities (India) Pvt. Ltd.
The company filed an intimation with the National Stock Exchange of India and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure ensures transparency regarding interactions between the company and market participants.
Visit details and compliance
The plant visit is scheduled for the Dahej location, a key operational hub for the company. The schedule remains subject to change due to exigencies on the part of the analysts, investors, or the company.
| Detail | Information |
|---|---|
| Organizer | Elara Securities (India) Pvt. Ltd. |
| Date | October 22, 2026 |
| Mode | Plant Visit |
| Location | Dahej, Gujarat |
Regulatory adherence
Epigral confirmed that no unpublished price sensitive information (UPSI) will be shared or discussed during the plant visit. This statement aligns with standard regulatory protocols to ensure a level playing field for all investors.
The company’s Company Secretary and Compliance Officer, Gaurang Trivedi, signed the digital filing dated October 21, 2026. The notice was submitted to both stock exchanges for the information of members.
Historical Stock Returns for Epigral
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.09% | -6.06% | -15.46% | -19.80% | -44.90% | +7.73% |
How might the insights shared during the Dahej plant visit influence Elara Securities' upcoming price targets and earnings estimates for Epigral?
What specific capacity expansion or technological upgrades at the Dahej facility are analysts expected to evaluate for future growth potential?
Could the transparency measures taken during this visit signal a broader strategic shift in Epigral's investor relations approach ahead of its next quarterly results?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
